Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Cord Blood Stem Cells for Brain Injury in Preterm Infants
NCT03696745Phase 1Unknown
- Sponsor
- Guangdong Women and Children Hospital
- Start
- Nov 2018
- Primary completion
- Sep 2020
- Modality
- Stem Cell Therapies
01
Overview
Phase 1, randomised trial of autologous umbilical cord blood in hypoxic-ischemic encephalopathy (HIE) (2 arms), sponsored by Guangdong Women and Children Hospital. Primary endpoint: Safety of autologous umbilical cord blood stem cells infusion at 24 hours. Status: unknown.
02
Drugs
autologous umbilical cord blood
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT03696745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03696745.